With over five years of nursing experience in emergency medicine and correctional healthcare, Sadie brings a compassionate, patient-centered approach to wellness and functional health
Harris, MRes at AXON Communications, for medical writing and editorial assistance (funded by Novo Nordisk A/S, Denmark)
The STEP clinical trial series demonstrated that weekly semaglutide 2.4 mg achieved 16.8% average weight loss in patients with obesity but without diabetes over 68 weeks, significantly better than placebo
In January 2026, the MHRA strengthened its warnings on pancreatitis risk for all GLP-1 medicines after rare reports of severe and fatal cases
If these signs are severe, persistent, or worrying, check in with your healthcare professional